• Profile
Close

Neutrophils: The double-edged swords in cancer's battleground

Newswise Jan 09, 2025

Neutrophils are the most abundant white blood cells in the human body, primarily recognised for their essential roles in fighting infections and regulating inflammation. However, their involvement in cancer progression has long been a subject of intrigue and confusion. These immune cells exhibit a paradoxical behaviour within tumours, where they can either promote or inhibit cancer growth. This dual functionality suggests that neutrophils are highly plastic, with their actions shaped by dynamic environmental cues within the tumour microenvironment (TME). Understanding this complexity is crucial for unravelling the full scope of their impact on cancer development and progression.

A team of researchers from the Department of Liver Surgery and Transplantation at the Liver Cancer Institute and Zhongshan Hospital, Fudan University, have published a review (DOI: 10.20892/j.issn.2095-3941.2024.0192) in Cancer Biology & Medicine. The paper delves into the nuanced roles neutrophils play within the TME, offering a detailed exploration of their heterogeneity and plasticity. The study presents a comprehensive synthesis of current research and identifies new therapeutic opportunities for targeting neutrophils in cancer treatment.

This review challenges the conventional view of neutrophils as mere short-lived effectors, focusing instead on their diversity and adaptability within the TME. The study traces the journey of neutrophils from their origins in the bone marrow to their specialised roles within tumours. Researchers emphasise how the local cytokine and chemokine landscape influences the recruitment and functional orientation of neutrophil subsets. Notably, the review highlights how these subsets, with distinct gene signatures and temporal functions, can influence tumour behaviour and patient outcomes. Subsets involved in antigen presentation and angiogenesis were identified as key players, linked to specific tumor types and clinical prognoses. This wealth of information provides a foundation for developing targeted immunotherapies that harness the unique dynamics of neutrophils.Dr. Qiang Gao, corresponding author of the study, explains, "Our findings challenge the conventional view of neutrophils as transient, effector cells. Instead, we reveal their remarkable heterogeneity and dynamic role in the TME. These insights are critical for designing more effective cancer therapies that leverage the full potential of the immune system."

The implications of this research are profound, offering new avenues for the development of prognostic models and targeted cancer therapies. By focusing on the plasticity of neutrophils and combining therapies that modulate their behavior, the study paves the way for more personalised and effective treatments. This new approach has the potential to enhance the immune system’s ability to fight cancer, opening doors to more advanced and tailored therapeutic strategies.

References

DOI: 10.20892/j.issn.2095-3941.2024.0192

Original Source URL : https://doi.org/10.20892/j.issn.2095-3941.2024.0192

Funding information

This work was supported by the National Natural Science Foundation of China (Grant Nos. 82130077, 81961128025, and 82121002), the Research Projects from the Science and Technology Commission of Shanghai Municipality (Grant Nos. 21JC1401200, 20JC1418900, and 21JC1410100) to QG, the China National Postdoctoral Program for Innovative Talents (Grant No. BX20240090), and the China Postdoctoral Science Foundation (Grant No. 2024M750551) to MZ.

About Cancer Biology & Medicine

Cancer Biology & Medicine (CBM) is a peer-reviewed open-access journal sponsored by China Anti-cancer Association (CACA) and Tianjin Medical University Cancer Institute & Hospital. The journal monthly provides innovative and significant information on the biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China. The journal is indexed in SCOPUS, MEDLINE and SCI (IF 5.6, 5-year IF 5.9), with all full texts freely visible to clinicians and researchers all over the world (http://www.ncbi.nlm.nih.gov/pmc/journals/2000/).

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay